Neoadjuvant Immune Checkpoint Inhibitors in hepatocellular carcinoma: a meta-analysis and systematic review.

Front Immunol · 2024 · PMC10909934 · PMID 38440727

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

( 21 ), on the other hand, found a higher RFS (Recurrence-Free Survival) in MPR/pCR (Pathological Complete Response) patients compared to non-MPR patients, although it did not reach statistical significance, possibly due to the small sample size.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.